The Janssen Biotech, Inc/Johnson & Johnson COVID-19 vaccine received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) on February 27, joining the Pfizer-BioNTech and Moderna vaccines that received EUA in December 2020.
Imagine completely eliminating surgical site infections (SSIs) without significantly disrupting…
The poster presentations at the 2024 OR Manager Conference showcased…
From sharps and blood-soaked surgical instruments to discarded anesthetic agents,…